Impact of Cold Somatostatin Analog Administration on Somatostatin Receptor Imaging: A Systematic Review.
Fiche publication
Date publication
juin 2023
Journal
Clinical nuclear medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr IMPERIALE Alessio
Tous les auteurs :
Morland D, Laures N, Triumbari EKA, Perrier M, Imperiale A, Annunziata S, Rufini V
Lien Pubmed
Résumé
The interactions between the administration of cold somatostatin analogs (cSAs) and their radiolabeled counterpart remain unclear, and discontinuation before imaging is still advised as a precaution. The aim of this systematic review is to evaluate the consequences of cSA administration on tumoral and surrounding healthy organs' uptake at somatostatin receptor (SSTR) imaging with SPECT or PET.
Mots clés
Humans, Receptors, Somatostatin, Somatostatin, Octreotide, Tomography, Emission-Computed, Single-Photon, Neoplasms, Neuroendocrine Tumors
Référence
Clin Nucl Med. 2023 06 1;48(6):467-473